Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.59 |
| ▸ | PNMT | P11086 | 1/20 | 0.55 |
| ▸ | ACP3 | P15309 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | TDO2 | P48775 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1133391 | 0.83 | CES2 (0.54) | CES2PNMTACP3EPHX1IDO1 | |
| SCHEMBL15019058 | 0.81 | CES2 (0.55) | CES2PNMTACP3EPHX1IDO1 | |
| SCHEMBL22193351 | 0.79 | PNMT (0.61) | CES2PNMTACP3GRIN2BIDO1 | |
| SCHEMBL29099863 | 0.79 | CES2 (0.53) | CES2PNMTACP3EPHX1IDO1 | |
| SCHEMBL18952845 | 0.77 | CES2 (0.51) | CES2PNMTACP3EPHX1IDO1 | |
| SCHEMBL4077713 | 0.77 | CES2 (0.54) | CES2PNMTACP3EPHX1IDO1 | |
| Hydrochloric Acid SCHEMBL28079203 | 0.76 | CES2 (0.50) | CES2PNMTACP3EPHX1IDO1 | |
| SCHEMBL21343262 | 0.76 | CES2 (0.50) | CES2PNMTACP3EPHX1IDO1 | |
| SCHEMBL14161938 | 0.76 | CES2 (0.50) | CES2PNMTACP3EPHX1IDO1 | |
| SCHEMBL2407521 | 0.75 | CES2 (0.53) | CES2PNMTACP3EPHX1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210051958-A1 | PROCESS AND INTERMIDIATES FOR THE PREPARATION OF CERTAIN MESOIONIC PESTICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2021-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210051958-A1 | PROCESS AND INTERMIDIATES FOR THE PREPARATION OF CERTAIN MESOIONIC PESTICIDES | SCO2, AOC3, AOC2 | CES2 445/4885PNMT 3764/4885ACP3 3023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.